Friday, August 14, 2026

2026’s Game-Changer: Canine Influenza Vaccine “CaniFlu-max” Now Approved for Subcutaneous Injection

A new subcutaneous influenza vaccine for dogs, CaniFlu-max, enhances treatment flexibility and has a strong safety profile.

North Korean Military Violated MDL 10 Times In November Alone, Concentrated In Goseong Gangwon

North Korean forces have violated the Military Demarcation Line multiple times, prompting South Korean military responses without protocol changes.

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

Tag: Von Hippel-Lindau syndrome

High cost keeps breakthrough VHL drug out of reach for Korean patients, oncologist says

Patients with Von Hippel-Lindau syndrome face high treatment costs, limiting access to essential drugs like Welireg, which could reduce surgeries.

Top News

- Our Sponsors Ad -

Follow us